• Halozyme Provides 2020 Business Update And Financial Guidance

    10 days ago - By San Diego Biotechnology

    2020 Guidance of $230 Million to $245 Million in Revenues and $0.60 to $0.75 in Earnings Per Share - Anticipated ENHANZE® Partner Progress in 2020 Includes At Least One Potential FDA Approval, Three New Phase 3, One New Phase 2 and Five New Phase 1......
    Read more ...